Cutaneous signs of liver disease: Value for prognosis of severe fibrosis and cirrhosis

Liver International

Volumn 28, Issue 5, 2008, Pages 659-666

  Niederau, Claus ^a   Lange, Stefan ^b   Frühauf, Martin ^a   Thiel, Andreas ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Hepatitis B; Hepatitis C; Palmar erythema; Skin disease; Spider naevi

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; IMMUNOGLOBULIN; PROTHROMBIN;

ACNE; ADULT; AGE; ARTICLE; AUTOIMMUNE HEPATITIS; CARPAL TUNNEL SYNDROME; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRY SKIN; DUPUYTREN CONTRACTURE; ERYTHEMA; FATTY LIVER; FEMALE; GYNECOMASTIA; HAIR DISEASE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; JAUNDICE; LABORATORY TEST; LEUKOCYTE COUNT; LICHEN PLANUS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NAIL DISEASE; NEVUS; PATIENT REFERRAL; PETECHIA; PORPHYRIA CUTANEA TARDA; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; PROTHROMBIN TIME; PSORIASIS VULGARIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEX DIFFERENCE; SKIN BLEEDING; SKIN MANIFESTATION; SKIN PRURITUS; TELANGIECTASIA; THROMBOCYTE COUNT; TONGUE DISEASE; UNIVARIATE ANALYSIS; VITILIGO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SKIN;

EID: 42149083214     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01694.x     Document Type: Article

References (17)

1. National Institutes of Health. National Institutes of Health consensus development conference statement: Management of hepatitis C: 2002. Hepatology 2002; 36: 3-20.
2. Dienstag J. The role of liver biopsy in chronic hepatitis C. Hepatology 2002; 36: 152-60.
3. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500.
4. Poynard T. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-32.
5. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
6. Batts KP, Ludwig J. Chronic hepatitis - an update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-17.
7. Bedossa P, Poynard T. A algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-93.
8. Wai CT, Greenson JK, Fontana RJ, et al. A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
9. Lichtinghagen R, Bahr MJ. Noninvasive diagnosis of fibrosis in chronic liver disease. Expert Rev Mol Diagn 2004; 4: 715-26.
10. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
11. Manduca A, Oliphant TE, Dresner MA, et al. Magnetic resonance elastography: Non-invasive mapping of tissue elasticity. Med Image Anal 2001; 5: 237-54.
12. Gebo KA, Herlong HF, Torbenson MS, et al. Role of liver biopsy in management of chronic hepatitis C: A systematic review. Hepatology 2002; 36: 161-72.
13. Forns X, Ampurdanes S, Llovet JM. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive method. Hepatology 2002; 36: 986-92.
14. Thabut D, Simon M, Myers RP, et al. Non invasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 2003; 37: 1220-1.
15. Poordad FF. FIBROSpect II: A potential noninvasive test to assess hepatic fibrosis. Expert Rev Mol Diagn 2004; 4: 593-7.
16. Albanis E, Friedman SL. Noninvasive markers of hepatic fibrosis. Clin Persp Gastroenterol 2002; 5: 182-7.
17. Imbert-Bismut F, Messous D, Thibaut V, et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors. Clin Chem Lab Med 2004; 42: 323-33.